医学
克拉斯
胰腺癌
癌症
肿瘤科
内科学
癌症研究
结直肠癌
出处
期刊:JAMA
[American Medical Association]
日期:2022-07-12
卷期号:328 (2): 122-122
标识
DOI:10.1001/jama.2022.11439
摘要
Metastatic pancreatic cancer tumors shrank by nearly three-quarters 6 months after a patient received a single infusion of engineered autologous T cells targeting a common KRAS gene variant, according to a case study published in the New England Journal of Medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI